L Wang1, Y Wei2, L Xue3, Q Guo4, W Liu1,3. 1. Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Hebei, P.R.C. 2. Hebei General Hospital, Shijiazhuang, Hebei, P.R.C. 3. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education-Beijing), Palliative Care Center and Day Care, Peking University Cancer Hospital and Institute, Beijing, P.R.C. 4. School of Nursing, Capital Medical University, Beijing, P.R.C.
Abstract
Background: Patients with cancer experience various levels of loss of dignity. Exploring levels of loss of dignity and the factors that influence such losses for patients with cancer is rare, but important in palliative care in China. Methods: Participants were cancer patients with early and advanced cancer recruited from a tertiary cancer hospital in North China. Patients were surveyed to assess their level of loss of dignity and potentially relevant factors. Data were collected using the Patient Dignity Inventory, the MD Anderson Symptom Inventory-Chinese, the distress thermometer, the Hospital Anxiety and Depression Scale, and the 30-question core Quality of Life Questionnaire from the European Organisation for Research and Treatment of Cancer, and were analyzed using quantitative methods. Results: The study included 202 cancer patients, 143 of whom experienced mild loss of dignity (71%); 37, moderate loss of dignity (18%); and 10, severe loss of dignity (5%). The problems with dignity were slightly different in patients with early-stage disease than in those with advanced-stage disease. Loss of dignity in the patients was significantly correlated with psychological distress, symptom burden, and quality of life (p < 0.05). Logistic regression showed that age, Karnofsky performance status, anxiety, and symptom burden were significant predictors of loss of dignity. Conclusions: Most patients with early and advanced cancer experienced some level of loss of dignity. Loss of dignity was more likely for patients of younger age, high Karnofsky performance status, high symptom burden, and anxiety. Understanding the dignity of cancer patients and potentially relevant factors is of great value for implementing comprehensive palliative care in China.
Background: Patients with cancer experience various levels of loss of dignity. Exploring levels of loss of dignity and the factors that influence such losses for patients with cancer is rare, but important in palliative care in China. Methods:Participants were cancerpatients with early and advanced cancer recruited from a tertiary cancer hospital in North China. Patients were surveyed to assess their level of loss of dignity and potentially relevant factors. Data were collected using the Patient Dignity Inventory, the MD Anderson Symptom Inventory-Chinese, the distress thermometer, the Hospital Anxiety and Depression Scale, and the 30-question core Quality of Life Questionnaire from the European Organisation for Research and Treatment of Cancer, and were analyzed using quantitative methods. Results: The study included 202 cancerpatients, 143 of whom experienced mild loss of dignity (71%); 37, moderate loss of dignity (18%); and 10, severe loss of dignity (5%). The problems with dignity were slightly different in patients with early-stage disease than in those with advanced-stage disease. Loss of dignity in the patients was significantly correlated with psychological distress, symptom burden, and quality of life (p < 0.05). Logistic regression showed that age, Karnofsky performance status, anxiety, and symptom burden were significant predictors of loss of dignity. Conclusions: Most patients with early and advanced cancer experienced some level of loss of dignity. Loss of dignity was more likely for patients of younger age, high Karnofsky performance status, high symptom burden, and anxiety. Understanding the dignity of cancerpatients and potentially relevant factors is of great value for implementing comprehensive palliative care in China.
Entities:
Keywords:
Dignity; influencing factors; loss of dignity; quality of life
Authors: Thomas F Hack; Susan E McClement; Harvey M Chochinov; Beverley J Cann; Thomas H Hassard; Linda J Kristjanson; Mike Harlos Journal: Palliat Med Date: 2010-07-06 Impact factor: 4.762
Authors: W Breitbart; B Rosenfeld; H Pessin; M Kaim; J Funesti-Esch; M Galietta; C J Nelson; R Brescia Journal: JAMA Date: 2000-12-13 Impact factor: 56.272
Authors: Thomas F Hack; Harvey Max Chochinov; Thomas Hassard; Linda J Kristjanson; Susan McClement; Mike Harlos Journal: Psychooncology Date: 2004-10 Impact factor: 3.894
Authors: R Philipp; A Mehnert; C Lehmann; K Oechsle; C Bokemeyer; A Krüll; S Vehling Journal: Support Care Cancer Date: 2016-01-27 Impact factor: 3.603
Authors: Keith Zi Yuan Chua; Elaine Li Ying Quah; Yun Xue Lim; Chloe Keyi Goh; Jieyu Lim; Darius Wei Jun Wan; Simone Meiqi Ong; Chi Sum Chong; Kennan Zhi Guang Yeo; Laura Shih Hui Goh; Ray Meng See; Alexia Sze Inn Lee; Yun Ting Ong; Min Chiam; Eng Koon Ong; Jamie Xuelian Zhou; Crystal Lim; Simon Yew Kuang Ong; Lalit Krishna Journal: BMC Palliat Care Date: 2022-07-04 Impact factor: 3.113